The new tablets — the generic version of Novartis Pharmaceuticals Corp’s Myfortic delayed-release tablets — are used to prevent organ rejection in patients receiving kidney transplants.
from Top Business News- News18.com https://ift.tt/3e2UU1i
Home
Top Business News- News18.com
Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market
0 comments: